Larissa Lutz

Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients

Alexandre Prehn Zavascki, Luciano Zubaran Goldani, Guoying Cao et al. · Clinical Infectious Diseases · 2008 · 232 citations · Full text

Pharmacotherapy, Antimicrobial Chemotherapy, Physiologically-based Pharmacokinetic Modeling +21

Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis

Ana Cristina Gales, Hélio S. Sader, Santiago Andrade et al. · International Journal of Antimicrobial Agents · 2006 · 122 citations

Health Sciences, Pulmonary Infection, Healthcare-associated Infection +10

Emergence of NDM-1-producing Enterobacteriaceae in Porto Alegre, Brazil

Franciéli Pedrotti Rozales, Vanessa Bley Ribeiro, Cibele Massotti Magagnin et al. · International Journal of Infectious Diseases · 2014 · 65 citations · Full text

Evaluation of heteroresistance to polymyxin B among carbapenem-susceptible and -resistant Pseudomonas aeruginosa

Djuli Milene Hermes, Caroline Pormann Pitt, Larissa Lutz et al. · Journal of Medical Microbiology · 2013 · 55 citations

Heteroresistant Subpopulations, Antibiotic Resistance, Bacterial Pathogens +18

Macrolides decrease the minimal inhibitory concentration of anti-pseudomonal agents against Pseudomonas aeruginosa from cystic fibrosis patients in biofilm

Larissa Lutz, Dariane Castro Pereira, Rodrigo Minuto Paiva et al. · BMC Microbiology · 2012 · 52 citations · Full text